Literature DB >> 31618425

miR-590-3p Inhibits Pyroptosis in Diabetic Retinopathy by Targeting NLRP1 and Inactivating the NOX4 Signaling Pathway.

Chufeng Gu1,2, Deji Draga3, Chuandi Zhou1,2, Tong Su1,2, Chen Zou4, Qing Gu1,2, Tashi Lahm3, Zhi Zheng1,2, Qinghua Qiu1,2,3.   

Abstract

Purpose: To elucidate the mechanism whereby miR-590-3p regulates pyroptosis in diabetic retinopathy (DR).
Methods: Human retinal microvascular endothelial cells (HRMECs) incubated with high glucose (HG) were used to establish cell models, and the expression levels of miR-590-3p, caspase-1, IL-1β, NLRP1, NOX4, TXNIP, NLRP3, and ROS were determined. Additionally, miR-590-3p was altered using a mimic or an inhibitor, and siRNAs targeting NLRP1 and NOX4 were applied to explore the regulatory mechanism of miR-590-3p in DR. The relationships between miR-590-3p and NLRP1/NOX4 also were investigated using a luciferase reporter assay. Furthermore, vitreous tissue samples were collected to confirm pyroptosis in clinical DR.
Results: Downregulated miR-590-3p and upregulated NLRP1/NOX4 levels were observed in a cell culture model of DR. Inhibiting miR-590-3p upregulated NLRP1, the NOX4/ROS/TXNIP/NLRP3 pathway, and caspase-1. NLRP1 and NOX4 were confirmed as direct target genes of miR-590-3p. The overexpression of miR-590-3p or knockdown of NLRP1 and NOX4 increased cell activity and suppressed pyroptosis. Intriguingly, the upregulation of IL-1β induced the downregulation of miR-590-3p by lowering the DNA promoter activity of pri-miR-590. Conclusions: HG induced pyroptosis in a cell culture model of DR, and the downregulation of miR-590-3p promoted pyroptotic death by targeting NLRP1 and activating the NOX4/ROS/TXNIP/NLRP3 pathway via an IL-1β-mediated positive feedback loop.

Entities:  

Year:  2019        PMID: 31618425     DOI: 10.1167/iovs.19-27825

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  34 in total

1.  Expression and Mechanism of TXNIP/NLRP3 Inflammasome in Sciatic Nerve of Type 2 Diabetic Rats.

Authors:  Le Han; Guangxia Xi; Na Guo; Jing Guo; Qingfeng Rong
Journal:  Dis Markers       Date:  2022-07-08       Impact factor: 3.464

Review 2.  Targeting Novel Regulated Cell Death: Pyroptosis, Necroptosis, and Ferroptosis in Diabetic Retinopathy.

Authors:  Sheng Gao; Yun Zhang; Meixia Zhang
Journal:  Front Cell Dev Biol       Date:  2022-06-23

Review 3.  Spotlight on pyroptosis: role in pathogenesis and therapeutic potential of ocular diseases.

Authors:  Meini Chen; Rong Rong; Xiaobo Xia
Journal:  J Neuroinflammation       Date:  2022-07-14       Impact factor: 9.587

4.  Ginsenoside Rg1 Alleviates Podocyte Injury Induced by Hyperlipidemia via Targeting the mTOR/NF-κB/NLRP3 Axis.

Authors:  Tao Wang; Yanbin Gao; Rongchuan Yue; Xiaolei Wang; Yimin Shi; Jiayi Xu; Bingjie Wu; Yimeng Li
Journal:  Evid Based Complement Alternat Med       Date:  2020-10-09       Impact factor: 2.629

5.  MicroRNA-409-5p promotes retinal neovascularization in diabetic retinopathy.

Authors:  Ying Wang; Wenwen Lin; Jianghua Ju
Journal:  Cell Cycle       Date:  2020-04-15       Impact factor: 4.534

6.  A novel miR-338-3p/SLC1A5 axis reprograms retinal pigment epithelium to increases its resistance to high glucose-induced cell ferroptosis.

Authors:  Jing Zhou; Caoyu Sun; Xu Dong; Hui Wang
Journal:  J Mol Histol       Date:  2022-03-23       Impact factor: 2.611

7.  Punicalagin Protects Diabetic Nephropathy by Inhibiting Pyroptosis Based on TXNIP/NLRP3 Pathway.

Authors:  Xin An; Yahui Zhang; Yuan Cao; Jihua Chen; Hong Qin; Lina Yang
Journal:  Nutrients       Date:  2020-05-22       Impact factor: 5.717

Review 8.  NLRP3 inflammasome in endothelial dysfunction.

Authors:  Baochen Bai; Yanyan Yang; Qi Wang; Min Li; Chao Tian; Yan Liu; Lynn Htet Htet Aung; Pei-Feng Li; Tao Yu; Xian-Ming Chu
Journal:  Cell Death Dis       Date:  2020-09-18       Impact factor: 8.469

9.  Expression of microRNA-155-5p in patients with refractory diabetic macular edema and its regulatory mechanism.

Authors:  Junwen He; Rui Zhang; Shan Wang; Lu Xie; Chengfeng Yu; Tao Xu; Yanzi Li; Tao Yan
Journal:  Exp Ther Med       Date:  2021-07-08       Impact factor: 2.447

10.  Atypical cytomegalovirus retinal disease in pyroptosis-deficient mice with murine acquired immunodeficiency syndrome.

Authors:  Jessica J Carter; Judee Grace E Nemeno; Jay J Oh; John E Houghton; Richard D Dix
Journal:  Exp Eye Res       Date:  2021-06-05       Impact factor: 3.770

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.